Davis Investment Partners LLC Purchases 32,406 Shares of First Trust Nasdaq Pharmaceuticals ETF $FTXH

Davis Investment Partners LLC purchased a new position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 32,406 shares of the company’s stock, valued at approximately $1,344,000. Davis Investment Partners LLC owned about 0.12% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Asset Dedication LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter valued at $25,000. Compass Financial Management LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter worth about $29,000. Claro Advisors Inc. acquired a new position in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at about $312,000. Flagship Harbor Advisors LLC raised its stake in First Trust Nasdaq Pharmaceuticals ETF by 50.9% in the 3rd quarter. Flagship Harbor Advisors LLC now owns 8,500 shares of the company’s stock valued at $352,000 after purchasing an additional 2,868 shares during the last quarter. Finally, Vivaldi Capital Management LP raised its stake in First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after purchasing an additional 1,741 shares during the last quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 0.0%

NASDAQ:FTXH opened at $44.36 on Wednesday. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of 32.96 and a beta of 0.45. The company’s 50-day moving average is $41.95 and its two-hundred day moving average is $37.56. First Trust Nasdaq Pharmaceuticals ETF has a 12-month low of $30.69 and a 12-month high of $45.10.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Thursday, September 24th were issued a dividend of $0.0113 per share. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.1%. This is a drop from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date was Thursday, September 24th.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.